Pinnacle Bancorp Inc. Sells 157 Shares of Solventum Co. (NYSE:SOLV)

Pinnacle Bancorp Inc. trimmed its holdings in shares of Solventum Co. (NYSE:SOLV) by 24.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 474 shares of the company’s stock after selling 157 shares during the quarter. Pinnacle Bancorp Inc.’s holdings in Solventum were worth $31,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. Copeland Capital Management LLC purchased a new position in Solventum during the 3rd quarter worth $26,000. Modus Advisors LLC bought a new position in shares of Solventum during the 4th quarter worth $25,000. Mather Group LLC. purchased a new position in shares of Solventum during the third quarter valued at $27,000. Hollencrest Capital Management bought a new stake in shares of Solventum in the second quarter valued at about $25,000. Finally, True Wealth Design LLC lifted its stake in Solventum by 23,550.0% in the third quarter. True Wealth Design LLC now owns 473 shares of the company’s stock worth $33,000 after acquiring an additional 471 shares during the period.

Wall Street Analyst Weigh In

Several research firms have recently commented on SOLV. Morgan Stanley boosted their price target on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a report on Monday, November 11th. Stifel Nicolaus started coverage on shares of Solventum in a report on Tuesday, October 8th. They set a “buy” rating and a $82.00 price objective on the stock. Piper Sandler upped their target price on Solventum from $71.00 to $75.00 and gave the stock a “neutral” rating in a report on Friday, November 8th. Mizuho started coverage on Solventum in a report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Finally, Wolfe Research began coverage on Solventum in a research report on Thursday, September 26th. They issued a “peer perform” rating for the company. One research analyst has rated the stock with a sell rating, nine have issued a hold rating and one has given a buy rating to the company’s stock. According to MarketBeat, Solventum presently has a consensus rating of “Hold” and an average target price of $68.29.

Solventum Price Performance

Shares of Solventum stock opened at $73.60 on Friday. The company has a 50 day moving average price of $69.09 and a 200 day moving average price of $65.34. The company has a quick ratio of 0.83, a current ratio of 1.15 and a debt-to-equity ratio of 2.45. Solventum Co. has a 52 week low of $47.16 and a 52 week high of $96.05.

Solventum Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.